Poland· PL-100405194
Tolak
A fluorouracil product containing fluorouracilum, registered in Poland by Pierre Fabre Medicament. The same ATC class is registered in 14 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Fluorouracil is registered in 14 of 19 countries.
Countries holding a registration under ATC L01BC02 (fluorouracil), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Fluorouracil · ATC L01BC02
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Fluorouracilum
- Manufacturer
- Pierre Fabre Medicament
- Country
- Poland (PL)
- ATC code
- L01BC02
- ATC class
- Fluorouracil
- Defined daily dose
- 0.15 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909991433017
- gtin05909991433024
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
401 interactions on record for fluorouracil.
Graded by severity as the source publishes them — 36 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Fluorouracil · interactions on record
401 records
- 36 severe
- 119 moderate
- 18 minor
- 227 info
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- Folic acidB03BB01severe
- CladribineL01BB04severe
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Fluorouracil in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenTolak 40 mg/g KrämMedartuum AB
- NorwayTolak2care4 ApS
- FinlandTolerakParanova Oy
- SwitzerlandTolak 40 mg/g, CremePierre Fabre Pharma SA
- CzechiaTOLAKPIERRE FABRE MEDICAMENT, Lavaur
- United StatesTOLAKHILL DERMACEUTICALS, INC.
- SpainTOLAK 40 MG/G CREMAPierre Fabre Iberica S.A.
- FranceTOLAK 40 mg/g, crèmePIERRE FABRE MEDICAMENT
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · 5-Fluorouracil Ebewe, Fluorouracil Accord
- Belgium · Efflurak, Efudix
- Bulgaria · 5-Флуороурацил “ебеве”, Флуороурацил Акорд
- Cyprus · Fluorouracil Accord
- Czechia · 5-Fluorouracil Ebewe, Fluorouracil Accord
- Germany · 5-Fu Medac, Benda-5 Fu
- Denmark · Fluorouracil Accord, Tolak
- Estonia · 5-Fluorouracil Ebewe, Fluorouracil Accord
- Spain · Fluorouracilo Accord, Tolak
- Finland · Fluorouracil Accord, Tolerak
- France · Efudix, Fluorouracile Accord
- United Kingdom (Northern Ireland) · Efudix, Fluorouracil Accord Healthcare
- Greece · Fluorouracil Anabiosis, Fluorouracil Opus
- Croatia · Fluorouracil Accord, Fluorouracil Sandoz
- Hungary · 5-Fluorouracil Ebewe, 5-Fluorouracil Sandoz
- Ireland · Efudix, Fluorouracil Accord
- Iceland · Flúoróúracíl Accord
- Italy · Fluorouracil Teva, Fluorouracile Ahcl
- Lithuania · Fluorouracil Accord
- Luxembourg · Efflurak, Efudix
- Latvia · Fluorouracil Accord
- Malta · Efudix
- Netherlands · Efudix, Fluorouracil Accord
- Norway · Fluorouracil Accord, Tolak
- Portugal · Efflurak, Fluorouracilo Accord
- Romania · 5-Fluorouracil, 5-Fluorouracil Ebewe
- Sweden · Fluorouracil Accord, Fluorouracil Teva
- Slovenia · 5-Fluorouracil Ebewe, Fluorouracil Accord
- Slovakia · Efudix, Fluorouracil Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d43dd8ff-bf1a-4cf7-b753-697e01754eb8 GET /v1/drugs/d43dd8ff-bf1a-4cf7-b753-697e01754eb8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Krem",
"source": "urpl",
"strength": "40 mg/g",
"packaging": "05909991433017 ¦ Rp ¦ 136794\n1 tuba 40 g\n05909991433024 ¦ Rp ¦ 136795\n1 tuba 20 g",
"substance": "Fluorouracilum 40 mg/g",
"common_name": "Fluorouracilum",
"pl_product_id": "100405194",
"pozwolenie_nr": "25952",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}See everything about fluorouracil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.